Literature DB >> 17884865

Screening for familial hypercholesterolaemia.

Ned Calonge, Janelle Guirguis-Blake.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17884865      PMCID: PMC1988985          DOI: 10.1136/bmj.39335.668646.80

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Screening for lipid disorders in children: US Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Pediatrics       Date:  2007-07       Impact factor: 7.124

2.  National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1992-03       Impact factor: 7.124

Review 3.  Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.

Authors:  D Marks; D Wonderling; M Thorogood; H Lambert; S E Humphries; H A Neil
Journal:  Health Technol Assess       Date:  2000       Impact factor: 4.014

Review 4.  Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force.

Authors:  Elizabeth M Haney; Laurie Hoyt Huffman; Christina Bougatsos; Michele Freeman; Robert D Steiner; Heidi D Nelson
Journal:  Pediatrics       Date:  2007-07       Impact factor: 7.124

5.  Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.

Authors:  David S Wald; Jonathan P Bestwick; Nicholas J Wald
Journal:  BMJ       Date:  2007-09-13
  5 in total
  2 in total

1.  Cascade Screening for Familial Hypercholesterolemia (FH).

Authors:  Renée M Ned; Eric J G Sijbrands
Journal:  PLoS Curr       Date:  2011-05-23

Review 2.  Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis.

Authors:  Leo E Akioyamen; Jacques Genest; Shubham D Shan; Rachel L Reel; Jordan M Albaum; Anna Chu; Jack V Tu
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.